The Bio Report
Levine Media Group
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Get every episode summarized
Each time The Bio Report publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Episodes (1239)
A Longevity Fund Focused on Young Companies
The Bio Report
Learning from “Elite” Responders to Develop Better Immunotherapies
The Bio Report
Bringing Precision Medicine to the Treatment of Obesity
The Bio Report
Expanding the Promise of RNA Therapies
The Bio Report
Triggering a Systemic Immune Response Against Cancer
The Bio Report
Targeting RNA Dysregulation in Cancer
The Bio Report
Building a Pipeline of Next-Generation Kinase Inhibitors
The Bio Report
Rethinking How Cell and Gene Therapies Are Made to Improve Accessibility
The Bio Report
Developing Next-Generation Radiopharmaceuticals
The Bio Report
Why Great Science and Data Aren’t Enough
The Bio Report
Targeting Sugars that Let Cancers Evade the Immune System
The Bio Report
Engineering Stem Cells to Withstand Targeted Therapies
The Bio Report
Targeting a Convergence of Signaling Pathways that Drive the Growth and Spread o...
The Bio Report
Moving from Preservation to Restoration with Off-the-Shelf Cell Therapies
The Bio Report
Using Gene Therapies to Treat Chronic, Inflammatory Conditions
The Bio Report
Unlocking the Full Potential of Antibody Therapies
The Bio Report
Combatting Superbugs and Emerging Viruses
The Bio Report
How a Plant-Derived Gel Halts Bleeding in Seconds
The Bio Report
Exploiting a Vulnerability in Cancers
The Bio Report
Democratizing AI
The Bio Report
A Rapid Onset Nasal Spray to Treat Mental Health Conditions
The Bio Report
A Regenerative Medicine Company Puts Its Off-the-Shelf Vessel Replacements to th...
The Bio Report
Battling Resistance in Tumors with “Pan-Variant” Kinase Inhibitors
The Bio Report
Treating Disease by Editing Genes in the Microbiome
The Bio Report
Embracing the Promise of Natural Killer Cells in the Fight Against Cancer
The Bio Report
Addressing Neurodegenerative Disease by Suppressing a Hyper Immune Response
The Bio Report
Bringing Precision Medicine to Psychiatry
The Bio Report
Attacking Neurodegenerative Diseases with Protein Degraders
The Bio Report
Restoring Immune Activity While Suppressing Cancer Proliferation
The Bio Report
A New Model for Preventing Life-Threatening Blood Clots
The Bio Report
The Race to Live Forever
The Bio Report
A Model for Moving from Breakthrough to Blockbuster
The Bio Report
Building the Next-Generation of Cell and Gene Therapies
The Bio Report
Building Small Molecule Drugs that Are Superior to Biologics
The Bio Report
A New Class of Cancer Therapies Targets Solid Tumors with a Dual Action
The Bio Report
A Pursuit of Off-The-Shelf CAR-T Therapies
The Bio Report
Mapping the Human Proteome
The Bio Report
Gene Therapy Provides Hope to Hemophilia B Patients
The Bio Report
Making Data-Driven Medicine a Reality
The Bio Report
A Neuroscientist Turned Venture Investor Discusses TechBio Investing
The Bio Report
A Nonprofit Seeks to Make Cell and Gene Therapies Affordable Worldwide
The Bio Report
Disposing Toxic Proteins to Treat Neurodegenerative Diseases
The Bio Report
Repurposing a Drug for Parasitic Infections as a Targeted GI Therapy
The Bio Report
Targeting Chronic, Low-Grade Inflammation to Address Diseases of Aging
The Bio Report
The Year in Biotech and What’s Ahead in 2022
The Bio Report
Restoring the Guardian of the Genome to Fight Tumors
The Bio Report
Advancing a Cell Therapy with the Potential to Cure HIV
The Bio Report
Harnessing More Efficient Organisms to Reshore BioManufacutring
The Bio Report
Using Digital Health Technology to Bring the Trial to the Patient
The Bio Report
Using the Body’s Housecleaning Mechanism to Target Undruggable Proteins
The Bio Report